Found 33 matching trials
The Hemophilia Inhibitor Prevention Trial
PHASE3This is a multi-center randomized phase III clinical trial, the Inhibitor P...
Location
University of Arkansas Medical Sciences Childrens Hospital
The Hemophilia Inhibitor Eradication Trial
PHASE3This is a multi-center randomized phase III clinical trial, the Inhibitor E...
Location
Hemophilia Center of Western PA
Emicizumab in Acquired Hemophilia A
PHASE2This study is an international, multicenter, open-label, single arm, prospe...
Location
Medizinische UniversitÀt Wien, HÀmatologie/HÀmostaseologie
Treatment of Hemophilia A Patients With FVIII Inhibitors
N/AThis is a non-interventional, multicenter, observational, international stu...
Location
Arthur M. Blank Hospital
Low Dose Emicizumab vs Low Dose Factor VIII in Prophylaxis in Hemophilia A Patients
PHASE2Low dose factor VIII prophylaxis is practiced around the world. Role of sta...
Location
Dhaka Medical College Hospital
Pharmacokinetic-guided Dosing of Emicizumab
PHASE4The goal of this multicentre, prospective, open-label, cross-over clinical ...
Location
Radboud University Medical Center
Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
PHASE1Von Willebrand Disease (VWD) is the most common inherited bleeding disorder...
Location
The Center for Comprehensive Care and Diagnosis of Inherited Blood Disorders (CIBD)
Hemophilia Inhibitor Clinical Trials (INHIBIT) Platform
PHASE3This study will evaluate if Eloctate is superior to Emicizumab in reducing ...
Location
Hemophilia Center of Western Pennsylvania
Emicizumab in Patients With Acquired Hemophilia A
PHASE2This is a phase II multicenter open-label, single-arm prospective study to ...
Status
Active Not Recruiting
Location
UCSD Hemophilia and Thrombosis Treatment Center
HemLibra Prophylaxis in Patients With Hemophilic Pseudotumor
PHASE4This is a single arm, phase 4, prospective, open-label, United States singl...
Location
Indiana Hemophila @Thrombosis Center